Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018
Philipp Kohler, Aline Wolfensberger, Susanne Stampf, Andreas Brönnimann, Katia Boggian, Christian Van Delden, Melody Favre, Cédric Hirzel, Nina Khanna, Stefan P Kuster, Oriol Manuel, Dionysios Neofytos, Silvio Ragozzino, Peter W Schreiber, Laura Walti, Nicolas J Mueller & Swiss Transplant Cohort Study
In Swiss SOT-recipients, proportion of infections with ESBL-producing non-E. coli Enterobacterales increased in recent years. Antibiotic pre-treatment represents a risk factor for ESBL-E. Improving appropriateness of empiric antibiotic treatment might be an important measure to reduce unfavourable outcome, which was observed in almost half of SOT-recipients with ESBL-E infections.
|citation||Kohler P, Wolfensberger A, Stampf S, Brönnimann A, Boggian K, van Delden C, Favre M, Hirzel C, Khanna N, Kuster S P, Manuel O, Neofytos D, Ragozzino S, Schreiber P W, Walti L, Mueller N J, Swiss Transplant Cohort Study . Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018. Antimicrob Resist Infect Control 2021; 10:50.|
|type||journal paper/review (English)|
|date of publishing||07-03-2021|
|journal title||Antimicrob Resist Infect Control (10/1)|